Showing results (951-960 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|July 29, 2025
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinomaThomas B Powles, Enrique Grande, Nimira Alimohamed, et al.
Future Oncology (London, England)|August 17, 2021
The risk and prognosis of secondary primary malignancy in lung cancer: a population-based studyJia Hong, Rongrong Wei, Chuang Nie, et al.
Future Oncology (London, England)|August 20, 2021
Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphomaSaaya Tsutsué, Shinichi Makita, Jingbo Yi, et al.
Future Oncology (London, England)|August 18, 2021
ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into realityMassimiliano Salati, Konstantinos Venetis, Matteo Fassan, et al.
Future Oncology (London, England)|August 24, 2021
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancerAna Oaknin, Anna V Tinker, Lucy Gilbert, et al.
Future Oncology (London, England)|August 25, 2021
Perioperative change in neutrophil count predicts worse survival in esophageal squamous cell carcinomaQian Song, Junzhou Wu, Sheng Wang, et al.
Future Oncology (London, England)|August 25, 2021
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenibAli Yılmaz, Melih Şimşek, Zekeriya Hannarici, et al.
Future Oncology (London, England)|August 26, 2021
Primary treatment of advanced ovarian cancer: how does the 'real world' practice?Amaranta D Craig, Eduardo Garcia, Pamela N Peters, et al.
Future Oncology (London, England)|August 26, 2021
Overexpressed HGF promotes metastasis of squamous cell carcinoma of the head and neck through the PI3K/Akt and JNK signaling pathwaysNan Guo, Jiwang Liang, Xin Gao, et al.
Future Oncology (London, England)|August 6, 2021
Impact of lymph node ratio in patients with stage IIIC endometrial carcinoma treated with postoperative radiotherapyCem Onal, Sezin Yuce Sari, Guler Yavas, et al.
Pageof 452